How to buy ASLAN Pharmaceuticals stock - 17 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ASLAN Pharmaceuticals stock

Own ASLAN Pharmaceuticals stock in just a few minutes.

ASLAN Pharmaceuticals Limited is a biotechnology business based in the US. ASLAN Pharmaceuticals shares (ASLN) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in ASLAN Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for ASLAN Pharmaceuticals. Find the stock by name or ticker symbol: ASLN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ASLAN Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ASLAN Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of ASLAN Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

ASLAN Pharmaceuticals share price

Use our graph to track the performance of ASLN stocks over time.

ASLAN Pharmaceuticals shares at a glance

Information last updated 2021-03-18.
52-week rangeUSD$0.8707 - USD$6.75
50-day moving average USD$3.5085
200-day moving average USD$2.2397
Wall St. target priceUSD$8.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.045

Buy ASLAN Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ASLAN Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ASLAN Pharmaceuticals financials

Revenue TTM USD$189,710
Gross profit TTM USD$79.8 million
Return on assets TTM -49.34%
Return on equity TTM -5313.82%
Profit margin 0%
Book value $0.41
Market capitalisation USD$250.6 million

TTM: trailing 12 months

Shorting ASLAN Pharmaceuticals shares

There are currently 8,711 ASLAN Pharmaceuticals shares held short by investors – that's known as ASLAN Pharmaceuticals's "short interest". This figure is 47.7% down from 16,643 last month.

There are a few different ways that this level of interest in shorting ASLAN Pharmaceuticals shares can be evaluated.

ASLAN Pharmaceuticals's "short interest ratio" (SIR)

ASLAN Pharmaceuticals's "short interest ratio" (SIR) is the quantity of ASLAN Pharmaceuticals shares currently shorted divided by the average quantity of ASLAN Pharmaceuticals shares traded daily (recently around 871100). ASLAN Pharmaceuticals's SIR currently stands at 0.01. In other words for every 100,000 ASLAN Pharmaceuticals shares traded daily on the market, roughly 10 shares are currently held short.

However ASLAN Pharmaceuticals's short interest can also be evaluated against the total number of ASLAN Pharmaceuticals shares, or, against the total number of tradable ASLAN Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ASLAN Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ASLAN Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable ASLAN Pharmaceuticals shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ASLAN Pharmaceuticals.

Find out more about how you can short ASLAN Pharmaceuticals stock.

ASLAN Pharmaceuticals share dividends

We're not expecting ASLAN Pharmaceuticals to pay a dividend over the next 12 months.

ASLAN Pharmaceuticals share price volatility

Over the last 12 months, ASLAN Pharmaceuticals's shares have ranged in value from as little as $0.8707 up to $6.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ASLAN Pharmaceuticals's is 2.5614. This would suggest that ASLAN Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

ASLAN Pharmaceuticals overview

ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and a small molecule inhibitor targeting oncology. Its partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site